Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010 (2010), Article ID 251231, 16 pages
http://dx.doi.org/10.1155/2010/251231
Review Article

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma

1Children's Brain Tumour Research Centre, Medical School, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
2Department of Tissue Engineering, Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK

Received 15 December 2009; Accepted 2 February 2010

Academic Editor: Arkadiusz Dudek

Copyright © 2010 Ruman Rahman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [51 citations]

The following is the list of published articles that have cited the current article.

  • Lisheng Ge, Neil Hoa, Daniela A. Bota, Josephine Natividad, Andrew Howat, and Martin R. Jadus, “Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions,” Clinical and Developmental Immunology, vol. 2010, pp. 1–19, 2010. View at Publisher · View at Google Scholar
  • Puja Sapra, Patricia Kraft, Fabio Pastorino, Domenico Ribatti, Melissa Dumble, Mary Mehlig, Maoliang Wang, Mirco Ponzoni, Lee M. Greenberger, and Ivan D. Horak, “Potent and sustained inhibition of HIF-1 alpha and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects,” Angiogenesis, vol. 14, no. 3, pp. 245–253, 2011. View at Publisher · View at Google Scholar
  • Samuel Valable, Edwige Petit, Simon Roussel, Lena Marteau, Jerome Toutain, Didier Divoux, Franck Sobrio, Jerome Delamare, Louisa Barre, and Myriam Bernaudin, “Complementary information from magnetic resonance imaging and F-18-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model,” Nuclear Medicine And Biology, vol. 38, no. 6, pp. 781–793, 2011. View at Publisher · View at Google Scholar
  • Elizabeth Allen, Ian B. Walters, and Douglas Hanahan, “Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition,” Clinical Cancer Research, vol. 17, no. 16, pp. 5299–5310, 2011. View at Publisher · View at Google Scholar
  • Qiaoyu Li, Yan Zhang, Hongfeng Zhan, Zhicheng Yuan, Peisong Lu, Liping Zhan, and Wenlin Xu, “The Hedgehog signalling pathway and its prognostic impact in human gliomas,” Anz Journal of Surgery, vol. 81, no. 6, pp. 440–445, 2011. View at Publisher · View at Google Scholar
  • Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen, and Alfred H. Schinkel, “Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics,” Drug Metabolism And Disposition, vol. 39, no. 5, pp. 729–735, 2011. View at Publisher · View at Google Scholar
  • W. B. Pope, A. Lai, R. Mehta, H. J. Kim, J. Qiao, J. R. Young, X. Xue, J. Goldin, M. S. Brown, P. L. Nghiemphu, A. Tran, and T. F. Cloughesy, “Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma,” American Journal of Neuroradiology, vol. 32, no. 5, pp. 882–889, 2011. View at Publisher · View at Google Scholar
  • Peng Wang, Haining Zhen, Jiashu Zhang, Wei Zhang, Rui Zhang, Xin Cheng, Geng Guo, Xinggang Mao, Jingbo Wang, and Xiang Zhang, “Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo,” Molecular Carcinogenesis, vol. 51, no. 7, pp. 586–595, 2012. View at Publisher · View at Google Scholar
  • Stuart J. Smith, Hanna Tilly, Jennifer H. Ward, Donald C. Macarthur, James Lowe, Beth Coyle, and Richard G. Grundy, “CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma,” Acta Neuropathologica, vol. 124, no. 1, pp. 99–110, 2012. View at Publisher · View at Google Scholar
  • Ali S Arbab, “Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.,” Histology and histopathology, vol. 27, no. 5, pp. 549–57, 2012. View at Publisher · View at Google Scholar
  • Alicia Martinez-Gonzalez, Gabriel F. Calvo, Luis A. Perez Romasanta, and Victor M. Perez-Garcia, “Hypoxic Cell Waves Around Necrotic Cores in Glioblastoma: A Biomathematical Model and Its Therapeutic Implications,” Bulletin Of Mathematical Biology, vol. 74, no. 12, pp. 2875–2896, 2012. View at Publisher · View at Google Scholar
  • Flavia R.S. Lima, Suzana Assad Kahn, Rossana C. Soletti, Deborah Biasoli, Tercia Alves, Anna Carolina C. da Fonseca, Celina Garcia, Luciana Romão, José Brito, Rosenilde Holanda-Afonso, Jane Faria, Helena Borges, and Vivaldo Moura-Neto, “Glioblastoma: Therapeutic challenges, what lies ahead,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1826, no. 2, pp. 338–349, 2012. View at Publisher · View at Google Scholar
  • S. D. Wang, P. Rath, B. Lal, J-P Richard, Y. Li, C. R. Goodwin, J. Laterra, and S. Xia, “EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase,” Oncogene, vol. 31, no. 50, pp. 5132–5143, 2012. View at Publisher · View at Google Scholar
  • Sergiy V. Kushchayev, Yevgeniya S. Kushchayeva, Philip C. Wiener, Adrienne C. Scheck, Behnam Badie, and Mark C. Preul, “Monocyte-Derived Cells of the Brain and Malignant Gliomas: The Double Face of Janus,” World Neurosurgery, 2012. View at Publisher · View at Google Scholar
  • S.M. El Sayed, K. Fukui, R.M. Abou El-Magd, Y. Shishido, K. Yorita, S.P. Chung, D.H. Tran, T. Sakai, H. Watanabe, and S. Kagami, “D-amino acid oxidase-induced oxidative stress, 3-bromopyruvate and Citrate inhibit angiogenesis, exhibiting potent anticancer effects,” Journal of Bioenergetics and Biomembranes, vol. 44, no. 5, pp. 513–523, 2012. View at Publisher · View at Google Scholar
  • Lizbeth Robles Irizarry, Dolores Hambardzumyan, Ichiro Nakano, Candece L Gladson, and Manmeet S Ahluwalia, “Therapeutic targeting of VEGF in the treatment of glioblastoma,” Expert Opinion on Therapeutic Targets, vol. 16, no. 10, pp. 973–984, 2012. View at Publisher · View at Google Scholar
  • Han Shen, and Kerrie L. McDonald, “The Complexities of Resistance to Bevacizumab,” Journal of Cancer Therapy, vol. 03, no. 05, pp. 491–503, 2012. View at Publisher · View at Google Scholar
  • Joseph L. Lasky III, and Ichiro Nakano, “Overview of brain tumor stem cells - Implications for treatment,” Current Signal Transduction Therapy, vol. 8, no. 1, pp. 45–54, 2013. View at Publisher · View at Google Scholar
  • Chiu-Yen Chung, Jen-Tsung Yang, and Yung-Chih Kuo, “Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats,” Biomaterials, vol. 34, no. 37, pp. 9717–9727, 2013. View at Publisher · View at Google Scholar
  • Pasquale De Bonis, Giammaria Marziali, Vera Vigo, Simone Peraio, Angelo Pompucci, Carmelo Anile, and Annunziato Mangiola, “Antiangiogenic therapy for high-grade gliomas: current concepts and limitations,” Expert Review of Neurotherapeutics, vol. 13, no. 11, pp. 1263–1270, 2013. View at Publisher · View at Google Scholar
  • M. R. Lobo, S. C. Green, M. C. Schabel, G. Y. Gillespie, R. L. Woltjer, and M. M. Pike, “Quinacrine synergistically enhances the antivascular and antitumor efficacy of cediranib in intracranial mouse glioma,” Neuro-Oncology, 2013. View at Publisher · View at Google Scholar
  • Yu Kawanishi, Akira Tominaga, Hiromi Okuyama, Satoshi Fukuoka, Takahiro Taguchi, Yutaka Kusumoto, Toshio Yawata, Yasunori Fujimoto, Shiro Ono, and Keiji Shimizu, “ Regulatory effects of Spirulina complex polysaccharides on growth of murine RSV-M glioma cells through Toll-like receptor 4 ,” Microbiology and Immunology, vol. 57, no. 1, pp. 63–73, 2013. View at Publisher · View at Google Scholar
  • Irene García-Palmero, Pilar López-Larrubia, Sebastián Cerdán, and Antonio Villalobo, “ Nuclear magnetic resonance imaging of tumour growth and neovasculature performance in vivo reveals Grb7 as a novel antiangiogenic target ,” NMR in Biomedicine, 2013. View at Publisher · View at Google Scholar
  • Stephanie Hesse, Valerie Jouan-Hureaux, Stefania Sartini, Binbin Chen, Enrico Perspicace, Serge Schneider, Rino Ragno, Flavio Ballante, Federico Da Settimo, Beatrice Faivre, Concettina La Motta, and Gilbert Kirsch, “Design, synthesis and biological evaluation of new classes of thieno [3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2),” European Journal Of Medicinal Chemistry, vol. 63, pp. 765–781, 2013. View at Publisher · View at Google Scholar
  • Alex L. Tobias, Atique U. Ahmed, Maciej S. Lesniak, Bart Thaci, Brenda Auffinger, Esther Rincón, Irina V. Balyasnikova, Chung Kwon Kim, Yu Han, Lingjiao Zhang, and Karen S. Aboody, “The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma,” Stem Cells Translational Medicine, vol. 2, no. 9, pp. 655–666, 2013. View at Publisher · View at Google Scholar
  • Isabel Arrillaga-Romany, and Andrew D Norden, “Antiangiogenic therapies for glioblastoma,” CNS Oncology, vol. 3, no. 5, pp. 349–358, 2014. View at Publisher · View at Google Scholar
  • Thomas Simon, Bérénice Coquerel, Alexandre Petit, Yusra Kassim, Elise Demange, Didier Le Cerf, Valérie Perrot, and Jean-Pierre Vannier, “Direct Effect of Bevacizumab on Glioblastoma Cell Lines In Vitro,” NeuroMolecular Medicine, 2014. View at Publisher · View at Google Scholar
  • Merryl R. Lobo, Xiaoyan Wang, G. Yancey Gillespie, Randall L. Woltjer, and Martin M. Pike, “Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation,” Plos One, vol. 9, no. 12, 2014. View at Publisher · View at Google Scholar
  • S. J. Smith, C. V. Rahman, P. A. Clarke, A. A. Ritchie, T. T. Gould, J. H. Ward, K. M. Shakesheff, R. G. Grundy, and R. Rahman, “Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma,” Annals of The Royal College of Surgeons of England, vol. 96, no. 7, pp. 495–501, 2014. View at Publisher · View at Google Scholar
  • Elisa Trevisan, Luca Bertero, Chiara Bosa, Michela Magistrello, Alessia Pellerino, Roberta Rudà, and Riccardo Soffietti, “Antiangiogenic therapy of brain tumors: the role of bevacizumab,” Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  • Wallys Garrido, Jose Dellis Rocha, Catherinne Jaramillo, Katia Fernandez, Carlos Oyarzun, Rody San Martin, and Claudia Quezada, “Chemoresistance in High-Grade Gliomas: Relevance of Adenosine Signalling in Stem-Like Cells of Glioblastoma Multiforme,” Current Drug Targets, vol. 15, no. 10, pp. 931–942, 2014. View at Publisher · View at Google Scholar
  • B.R. Achyut, Adarsh Shankar, Asm Iskander, Roxan Ara, Kartik Angara, Peng Zeng, Robert A. Knight, Alfonso G Scicli, and Ali S. Arbab, “Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Cheng Wang, Ying Shan, Jiuli Yang, Xuelian Xu, Bo Zhuang, Yingfang Fan, and Wei Xu, “Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles,” Journal of Biomedical Nanotechnology, vol. 11, no. 5, pp. 805–815, 2015. View at Publisher · View at Google Scholar
  • Christopher Bell, Nicholas Dowson, Mike Fay, Paul Thomas, Simon Puttick, Yaniv Gal, and Stephen Rose, “Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation,” Seminars in Nuclear Medicine, vol. 45, no. 2, pp. 136–150, 2015. View at Publisher · View at Google Scholar
  • Weijun Wang, Walavan Sivakumar, Shering Torres, Niyati Jhaveri, Vijaya Pooja Vaikari, Alex Gong, Adam Howard, Encouse B. Golden, Stan G. Louie, Axel H. Schönthal, Florence M. Hofman, and Thomas C. Chen, “Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals,” Neurosurgical Focus, vol. 38, no. 3, pp. E8, 2015. View at Publisher · View at Google Scholar
  • Merryl R. Lobo, Ayaka Kukino, Huong Tran, Matthias C. Schabel, Charles S. Springer, G. Yancey Gillespie, Marjorie R. Grafe, Randall L. Woltjer, and Martin M. Pike, “Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma,” Plos One, vol. 10, no. 12, 2015. View at Publisher · View at Google Scholar
  • Gecioni Loch-Neckel, Maira Assuncao Bicca, Paulo Cesar Leal, Alessandra Mascarello, Jarbas Mota Siqueira, and Joao B. Calixto, “In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid,” European Journal Of Medicinal Chemistry, vol. 90, pp. 93–100, 2015. View at Publisher · View at Google Scholar
  • Heng Cai, Yixue Xue, Zhen Li, Yi Hu, Zhenhua Wang, Wenjing Liu, Zhiqing Li, and Yunhui Liu, “Roundabout4 Suppresses Glioma-Induced Endothelial Cell Proliferation, Migration and Tube Formation in Vitro by Inhibiting VEGR2-Mediated PI3K/AKT and ,” Cellular Physiology And Biochemistry, vol. 35, no. 5, pp. 1689–1705, 2015. View at Publisher · View at Google Scholar
  • Jana Jaal, Marju Kase, Ave Minajeva, Mikk Saretok, Aidi Adamson, Jelizaveta Junninen, Tõnis Metsaots, Tõnu Jõgi, Madis Joonsalu, Markus Vardja, and Toomas Asser, “VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment,” International Journal of Inflammation, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Li-Ni Zhao, Ping Wang, Yun-Hui Liu, Heng Cai, Jun Ma, Li-Bo Liu, Zhuo Xi, Zhi-Qing Li, Xiao-Bai Liu, and Yi-Xue Xue, “MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways,” Cellular Signalling, 2016. View at Publisher · View at Google Scholar
  • Peng Jia, Heng Cai, Xiaobai Liu, Jiajia Chen, Jun Ma, Ping Wang, Yunhui Liu, Jian Zheng, and Yixue Xue, “Long non-coding RNA h19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells through inhibiting microRNA-29a,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Adarsh Shankar, Thaiz F. Borin, Asm Iskander, Nadimpalli R. S. Varma, Bhagelu R. Achyut, Meenu Jain, Tom Mikkelsen, Austin M. Guo, Wilson B. Chwang, James R. Ewing, Hassan Bagher-Ebadian, and Ali S. Arbab, “Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma,” Oncotargets And Therapy, vol. 9, pp. 1205–1219, 2016. View at Publisher · View at Google Scholar
  • Ali S Arbab, Meenu Jain, and Bhagelu R Achyut, “Cancer Therapeutics Following Newton's Third Law.,” Biochemistry & physiology, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Pei-Yu Chou, Hsien-Feng Liao, Chun-Hsu Pan, Yi-Fong Chen, Tian-Shung Wu, Ming-Jyh Sheu, and Chieh-Hsi Wu, “Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells,” PLoS ONE, vol. 12, no. 9, 2017. View at Publisher · View at Google Scholar
  • Hai-Li Lang, Guo-Wen Hu, Bo Zhang, Wei Kuang, Yong Chen, Lei Wu, and Guo-Hai Xu, “Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2,” Oncology Reports, vol. 38, no. 2, pp. 785–798, 2017. View at Publisher · View at Google Scholar
  • Kartik Angara, Thaiz F. Borin, and Ali S. Arbab, “Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma,” Translational Oncology, vol. 10, no. 4, pp. 650–660, 2017. View at Publisher · View at Google Scholar
  • Wang Shiying, Sun Boyun, Yuan Jianye, Zhang Wanjun, Tao Ping, Lin Jiang, and Hu Hongyi, “The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2,” Inflammatory Bowel Diseases, vol. 23, no. 4, pp. 603–616, 2017. View at Publisher · View at Google Scholar
  • Yawen Ma, Ping Wang, Yixue Xue, Chengbin Qu, Jian Zheng, Xiaobai Liu, Jun Ma, and Yunhui Liu, “PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186,” Tumor Biology, vol. 39, no. 3, pp. 101042831769432, 2017. View at Publisher · View at Google Scholar
  • Thomas Simon, Teresa Gagliano, and Georgios Giamas, “Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling,” Trends in Molecular Medicine, 2017. View at Publisher · View at Google Scholar
  • Ave Minajeva, Marju Kase, Mikk Saretok, Aidi Adamson-Raieste, Sandra Kase, Kristi Niinepuu, Markus Vardja, Toomas Asser, and Jana Jaal, “Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients,” Neuroscience Journal, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Niha Beig, Jay Patel, Prateek Prasanna, Virginia Hill, Amit Gupta, Ramon Correa, Kaustav Bera, Salendra Singh, Sasan Partovi, Vinay Varadan, Manmeet Ahluwalia, Anant Madabhushi, and Pallavi Tiwari, “Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma,” Scientific Reports, vol. 8, no. 1, 2018. View at Publisher · View at Google Scholar